The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Outcome-dependent sampling designs are strategic methodologies in longitudinal research that prioritise the selection of study subjects based on observed outcomes. Rather than relying on random ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results